Diabetes Clinical Trials in Dallas

Showing 281-284 of 284 trials

Effects of PN2034 in Insulin-Dependent Patients With Type 2 Diabetes

NCT00110864

This study is designed to evaluate the safety and efficacy of PN2034 in insulin-dependent type 2 diabetics as measured by the change in average daily insulin dose from baseline to week 12. The effects of PN2034 on HbA1c, fasting plasma glucose (FPG), and lipid levels will also be measured.

Type 2 Diabetes Mellitus

Wellstat Therapeutics90 participantsStarted May 2005

Waterbury, Connecticut, United States • Hollywood, Florida, United States • Longwood, Florida, United States +15 more locations

COMPLETEDPHASE2190 miles

An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 Diabetes

NCT00065312

The purpose of this study is to determine if an investigational drug is safe and efficacious for poorly controlled type 2 diabetes mellitus.

Diabetes Mellitus, Non-Insulin-Dependent

Eli Lilly and Company

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Peoria, Arizona, United States +39 more locations

Effects of PN2034 in Insulin-Dependent Patients With Type 2 Diabetes

An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 Diabetes

Diabetes Trials in Other Cities

A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control

Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients

Other Conditions in Dallas